Leader
|
|
|
00000cz a2200037n 45 0 |
001
|
|
|
SUDOC|16736636X
(VIAF cluster)
(Authority/Source Record)
|
005
|
|
|
202004091439.5 |
008
|
|
|
130212 nfazznn||| |n aaa |d |
003
|
|
|
SUDOC |
035
|
|
|
‡a
(SUDOC)16736636X
|
024
|
7 |
|
‡a
0000000400017179
‡2
isni
|
035
|
|
|
‡a
http://viaf.org/viaf/295801063
|
100
|
1 |
|
‡a
Sebastian, Mathew
|
670
|
|
|
‡a
Nanomedicine and drug delivery / Mathew Sebastian, A. K. Haghi, Neethu Ninan,2013
|
901
|
|
|
‡a
978192689517
‡9
1
|
903
|
|
|
‡a
201293567
‡9
1
|
909
|
|
|
‡a
(isni) 0000000400017179
‡9
1
|
910
|
|
|
‡a
nanomedicineanddrugdelivery
‡A
Nanomedicine and drug delivery /
‡l
eng
‡9
1
|
919
|
|
|
‡a
nanomedicineanddrugdelivery
‡A
Nanomedicine and drug delivery
‡9
1
|
920
|
|
|
‡a
978-192
‡9
1
|
921
|
|
|
‡a
apple academic press
‡b
Apple Academic Press,
‡9
1
|
922
|
|
|
‡a
cn
‡b
ca
‡9
1
|
930
|
|
|
‡a
mathew sebastian
‡c
edited by Mathew Sebastian, Neethu Ninan, and A.K. Haghi.
‡9
1
|
940
|
|
|
‡a
eng
‡9
1
|
941
|
|
|
‡a
editeur scientifique
‡e
Éditeur scientifique
‡9
1
|
942
|
|
|
‡a
R857.N34
‡9
1
|
943
|
|
|
‡a
201x
‡9
1
|
944
|
|
|
‡a
am
‡9
1
|
950
|
|
|
‡a
haghi a k
‡A
Haghi, A. K..
‡9
1
|
950
|
|
|
‡a
ninan neethu
‡A
Ninan, Neethu
‡d
(1985-....).
‡9
1
|
996
|
|
|
‡2
ISNI|0000000030446784
|
996
|
|
|
‡2
NSK|000068089
|
996
|
|
|
‡2
LC|n 88161788
|
996
|
|
|
‡2
DNB|170996913
|
996
|
|
|
‡2
CAOONL|ncf11592299
|
996
|
|
|
‡2
WKP|Q58322127
|
996
|
|
|
‡2
LC|n 93072809
|
996
|
|
|
‡2
WKP|Q112414408
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Sebastian, Mathew
‡2
LC|n 2012190251
‡3
standard number
|
998
|
|
|
‡a
Sebastian, Mathew
‡2
CAOONL|ncf10608724
‡3
standard number
|
998
|
|
|
‡a
Sebastian, Mathew
‡2
NKC|utb2013746995
‡3
exact name
|
998
|
|
|
‡a
Sebastian, Mathew
‡2
ISNI|0000000400017179
‡3
suggested
‡3
joint author: (1.00, 'haghi a k', 'haghi a k')
|
999
|
|
|
‡2
SUDOCBIB|16736216X
|